Shares of First Trust Indxx Medical Devices ETF (BATS:MDEV – Get Free Report) dropped 2.1% on Thursday . The company traded as low as $20.41 and last traded at $20.41. Approximately 8 shares were traded during trading, a decline of 98% from the average daily volume of 328 shares. The stock had previously closed at $20.84.
First Trust Indxx Medical Devices ETF Trading Down 0.3%
The company has a market cap of $2.04 million, a PE ratio of 29.75 and a beta of 1.05. The stock has a 50 day moving average price of $21.12 and a 200 day moving average price of $20.72.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in First Trust Indxx Medical Devices ETF stock. Jane Street Group LLC boosted its holdings in First Trust Indxx Medical Devices ETF (BATS:MDEV – Free Report) by 38.2% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,812 shares of the company’s stock after purchasing an additional 5,756 shares during the quarter. Jane Street Group LLC owned about 20.81% of First Trust Indxx Medical Devices ETF worth $428,000 at the end of the most recent quarter.
About First Trust Indxx Medical Devices ETF
The First Trust Indxx Global Medical Devices ETF (MDEV) is an exchange-traded fund that is based on the Indxx Global Medical Equipment index. The fund tracks an equal-weighted index that gives global exposure to the medical equipment industry. MDEV was launched on Jun 22, 2021 and is managed by First Trust.
Featured Articles
- Five stocks we like better than First Trust Indxx Medical Devices ETF
- Did you hear what Nvidia’s CEO said?
- Think You Missed Silver? You’re Wrong. Here’s Why.
- How Long Does $2.5M Last in Retirement?
- Your Bank Account Is No Longer Safe
- Huge robotics rollout underway
Receive News & Ratings for First Trust Indxx Medical Devices ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust Indxx Medical Devices ETF and related companies with MarketBeat.com's FREE daily email newsletter.
